rs2721176

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003923.3(FOXH1):​c.*20A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.989 in 1,519,038 control chromosomes in the GnomAD database, including 744,435 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.98 ( 73859 hom., cov: 34)
Exomes 𝑓: 0.99 ( 670576 hom. )

Consequence

FOXH1
NM_003923.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -3.17

Publications

7 publications found
Variant links:
Genes affected
FOXH1 (HGNC:3814): (forkhead box H1) FOXH1 encodes a human homolog of Xenopus forkhead activin signal transducer-1. FOXH1 protein binds SMAD2 and activates an activin response element via binding the DNA motif TGT(G/T)(T/G)ATT. [provided by RefSeq, Jul 2008]
KIFC2 (HGNC:29530): (kinesin family member C2) Predicted to enable microtubule binding activity and microtubule motor activity. Predicted to be involved in microtubule-based movement and mitotic spindle assembly. Predicted to be located in cytoplasm. Predicted to be part of kinesin complex. Predicted to be active in microtubule cytoskeleton and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 8-144474218-T-C is Benign according to our data. Variant chr8-144474218-T-C is described in ClinVar as Benign. ClinVar VariationId is 259199.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOXH1NM_003923.3 linkc.*20A>G 3_prime_UTR_variant Exon 3 of 3 ENST00000377317.5 NP_003914.1 O75593
KIFC2NM_001369769.2 linkc.*829T>C downstream_gene_variant ENST00000645548.2 NP_001356698.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOXH1ENST00000377317.5 linkc.*20A>G 3_prime_UTR_variant Exon 3 of 3 1 NM_003923.3 ENSP00000366534.4 O75593
KIFC2ENST00000645548.2 linkc.*829T>C downstream_gene_variant NM_001369769.2 ENSP00000494595.1 A0A2R8YEU8
KIFC2ENST00000301332.3 linkc.*768T>C downstream_gene_variant 1 ENSP00000301332.2 Q96AC6-1
KIFC2ENST00000643461.1 linkn.*16T>C downstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.984
AC:
149776
AN:
152196
Hom.:
73806
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.986
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.951
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
0.804
Gnomad SAS
AF:
0.997
Gnomad FIN
AF:
0.998
Gnomad MID
AF:
1.00
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.989
GnomAD2 exomes
AF:
0.965
AC:
165617
AN:
171596
AF XY:
0.971
show subpopulations
Gnomad AFR exome
AF:
0.987
Gnomad AMR exome
AF:
0.897
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
0.791
Gnomad FIN exome
AF:
0.997
Gnomad NFE exome
AF:
0.999
Gnomad OTH exome
AF:
0.980
GnomAD4 exome
AF:
0.990
AC:
1352452
AN:
1366724
Hom.:
670576
Cov.:
26
AF XY:
0.990
AC XY:
664836
AN XY:
671466
show subpopulations
African (AFR)
AF:
0.986
AC:
30133
AN:
30552
American (AMR)
AF:
0.907
AC:
29439
AN:
32470
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
20764
AN:
20766
East Asian (EAS)
AF:
0.753
AC:
29163
AN:
38746
South Asian (SAS)
AF:
0.998
AC:
72282
AN:
72422
European-Finnish (FIN)
AF:
0.996
AC:
48380
AN:
48554
Middle Eastern (MID)
AF:
0.997
AC:
5147
AN:
5160
European-Non Finnish (NFE)
AF:
1.00
AC:
1061622
AN:
1061884
Other (OTH)
AF:
0.988
AC:
55522
AN:
56170
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
650
1300
1951
2601
3251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21240
42480
63720
84960
106200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.984
AC:
149888
AN:
152314
Hom.:
73859
Cov.:
34
AF XY:
0.982
AC XY:
73156
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.986
AC:
40999
AN:
41572
American (AMR)
AF:
0.951
AC:
14556
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3472
AN:
3472
East Asian (EAS)
AF:
0.803
AC:
4144
AN:
5158
South Asian (SAS)
AF:
0.997
AC:
4816
AN:
4830
European-Finnish (FIN)
AF:
0.998
AC:
10605
AN:
10628
Middle Eastern (MID)
AF:
1.00
AC:
294
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68001
AN:
68028
Other (OTH)
AF:
0.988
AC:
2089
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
123
246
370
493
616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.994
Hom.:
15845
Bravo
AF:
0.978
Asia WGS
AF:
0.943
AC:
3280
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Dec 17, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 29, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Holoprosencephaly sequence Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
2.0
DANN
Benign
0.35
PhyloP100
-3.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2721176; hg19: chr8-145699601; COSMIC: COSV56762547; COSMIC: COSV56762547; API